Physician

Michael L Gross, MD

According to 2025 Medicare claims, Michael Gross, MD (NPI: 1386701654) practices rheumatology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is PHYSICIAN SPECIALISTS OF NORTHERN JERSEY LLC (NPI: 1952842460; TIN: 475590589) and primary practice location at 07652-3510. Gross is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Gross' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 678 traditional Medicare patients, billed 103,683 HCPCS/CPT codes, and received $1,219,663 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 6,189 prescription claims across 526 beneficiaries totaling $2,031,538 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2023 DME data shows 104 claims. Open Payments data shows 209 records totaling $5,113. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $1,046,015 to $2,031,538. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $7,855 to $793.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$610K$1.2M2015 Medicare payment: $879,119 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $717,029 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $892,694 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $913,483 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $929,430 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,015,471 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,024,806 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $984,192 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,036,061 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,219,663 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201569237,457$879,119
201660127,186$717,029
201763043,640$892,694
201864343,735$913,483
201959841,354$929,430
202059344,779$1,015,471
202162952,815$1,024,806
202266659,968$984,192
202364459,079$1,036,061
2024678103,683$1,219,663

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.2M2015 Drug cost: $1,046,015 (USD; Tot_Drug_Cst)2016 Drug cost: $894,291 (USD; Tot_Drug_Cst)2017 Drug cost: $1,143,081 (USD; Tot_Drug_Cst)2018 Drug cost: $1,423,075 (USD; Tot_Drug_Cst)2019 Drug cost: $1,330,969 (USD; Tot_Drug_Cst)2020 Drug cost: $1,510,843 (USD; Tot_Drug_Cst)2021 Drug cost: $1,442,805 (USD; Tot_Drug_Cst)2022 Drug cost: $1,977,196 (USD; Tot_Drug_Cst)2023 Drug cost: $2,232,454 (USD; Tot_Drug_Cst)2024 Drug cost: $2,031,538 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20154844,471$1,046,015
20164454,456$894,291
20174575,236$1,143,081
20184865,298$1,423,075
20195055,523$1,330,969
20204935,753$1,510,843
20214645,682$1,442,805
20225185,924$1,977,196
20235175,865$2,232,454
20245266,189$2,031,538

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$3.5K$7.0K2015 Medicare payment: $727 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $6,969 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $189 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $261 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $183 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $515 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $5,179 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/R52$727
20161125$6,969
2017N/R15$189
2018N/R19$261
2019N/R17$183
2020N/R13$515
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R104$5,179
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more135135$135
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more5722,097$105
20610Aspiration and/or injection of fluid from large joint150407$75
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's4241,090$14
J1010Injection, methylprednisolone acetate, 1 mg15635,924$0

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Humira(Cf) PenAdalimumab20560$213,269
Enbrel SureclickEtanercept28784$204,830
RinvoqUpadacitinib16540$115,828
SimponiGolimumab19558$110,873
Taltz AutoinjectorIxekizumab13364$86,632

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.209$5,113Janssen Biotech, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Michael L. Gross, MD?

Tedicare shows public-source Medicare data for Michael L. Gross, MD (NPI 1386701654), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Michael L. Gross, MD have ACO affiliation data?

Michael L. Gross, MD is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Michael L. Gross, MD?

Michael L. Gross, MD is linked to PHYSICIAN SPECIALISTS OF NORTHERN JERSEY LLC (billing NPI 1952842460) in the available physician profile data.

Does Michael L. Gross, MD have Open Payments data?

Michael L. Gross, MD has 209 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.